Teva api strengthens partnerships with customers at CPhI China
By TingTing Zhou, Associate Director of Teva api Sales
CPhI China, the industry event of the year in China, drew more than 30,000 pharmaceutical professionals to Shanghai last week, including Teva api customers from throughout the country. We were excited to introduce our new API's for China and meet face to face with customers.
Having the Teva api China team and our customers together in the same place provides an ideal setting to meet face-to-face, strengthen our partnerships, check in on current projects, discuss new business opportunities, and learn how we can make their customer experience even better. We made the most of our time in Shanghai – we held more than 30 meetings during the three-day event!
While the Teva api team regularly visits customers at their locations throughout the year, CPhI China enables us to have more in-depth discussions on ways we can collaborate more closely and help them stay competitive long-term. Because every customer has different needs, we offer a personalized approach to their customer experience, striving to exceed each individual’s expectations in every step of their Teva api journey.
At CPhI China this year, we had a lot of good news to share about the progress Teva api’s Regulatory Affairs (RA) team has made in China. Our customers were also excited to see the focus list of products coming down the road to China, including:
Would you like to learn more about one of the products? Send your inquiry now!
(Subject of course, to applicable patent restrictions).
One of hot topics at CPhI China was the China Food and Drug Administration’s call for manufacturers of approved generics to perform conformity assessments of their product portfolios, to make sure drug products sold in China are safe and effective. As we told our customers, Teva api will work closely with them every step of the way to help them with their assessment. Our rigorous standards for quality and industry-leading compliance ensure all of our products meet stringent standards worldwide, and our RA team’s in-depth knowledge of global regulatory requirements can give them that “extra” advantage.
Teva api has attended CPhI China since 2009 and we look forward to it every year. It means so much for our team to meet with key decision makers at the companies we serve, learn how we can continuously improve our service, and share exciting news about Teva api products and services that will soon be available in China.